Market Overview

UPDATE: Morgan Stanley Reiterates On Concord Medical Services Holdings Ltd. On Unsurprising 3Q14

Share:
Related CCM
Concord Medical Announces Withdrawal of Going Private Proposal
Earnings Scheduled For August 25, 2017

In a report published Tuesday, Morgan Stanley analyst Bin Li reiterated an Underweight rating on Concord Medical Services Holdings Ltd. (NYSE: CCM), but removed the $7.00 price target.

In the report, Morgan Stanley noted, “CCM's 3Q14 non-GAAP EPS of Rmb0.72 beat our estimate by 25%, mainly due to lower G&A expenses caused by the collection of bad debt. Management reiterated 2014 guidance of EPS of US$0.45-0.50 (+25-38% YoY), given the solid operation performance.”

Concord Medical Services Holdings Ltd. closed on Monday at $6.94.

Latest Ratings for CCM

DateFirmActionFromTo
Nov 2012Morgan StanleyMaintainsOverweight
Jul 2012Morgan StanleyMaintainsOverweight
Mar 2012JP MorganMaintainsOverweight

View More Analyst Ratings for CCM
View the Latest Analyst Ratings

Posted-In: Bin Li Morgan StanleyAnalyst Color Price Target Analyst Ratings

 

Related Articles (CCM)

View Comments and Join the Discussion!